RADFORSK
@radforsk.no
Radforsk has made a significant impact on cancer research and treatment in Norway. Since our establishment in 1987, we have focused on the commercialisation of cancer research in order to contribute to better treatment for each individual cancer patient. To pursue our goal of better cancer treatment, we invest in infrastructure through Radforsk Innovation and in companies through Radforsk Invest, and we link private enterprises with research environments. Our investments and innovation activities have resulted in several companies being listed, and in substantial growth for companies engaged in cancer treatment and related products on the global market. So far, Radforsk has allocated NOK 237 million from our profits to research and strategic projects at Oslo University Hospital. Radforsk Invest's role goes far beyond traditional financing, and we put a lot of effort into developing our portfolio companies. We are investors, entrepreneurs and developers of companies. Groundbreaking new cancer treatment takes time to develop, and our 'evergreen' model means that we have a long-term perspective. We contribute both strategically and operationally before, during and after companies are established. At Radforsk Invest, we take a global approach to our investments. Radforsk Innovation's role includes building ecosystems and infrastructure such as Oslo Cancer Cluster, Oslo Cancer Cluster Incubator and Oslo Cancer Cluster Innovation Park, which promote innovation and research on cancer treatment. The patient perspective is the core of Radforsk's philosophy. Our job is to bring new cancer treatment from the laboratory to the market, and to the patients who need it. This patient focus is reflected in our support for the development of therapies and technologies that address as yet unmet medical needs.
RADFORSK's Company Logos
RADFORSK's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#3333FF
Blue
51, 51, 255
240, 100, 60
80, 80, 0, 0
#F4A8D9
Illusion
244, 168, 217
321, 78, 81
0, 31, 11, 4
#160013
Toledo
22, 0, 19
308, 100, 4
0, 100, 14, 91
About RADFORSK
Radforsk is a highly successful pre-seed investment firm in Europe that focuses on oncology. As an early stage Evergreen Fund, Radforsk is dedicated to supporting cancer research and converting it into revenue. With a proven track record in immunotherapy investments, Radforsk has established itself as a leader in the field.
They work closely with the best minds in the industry, collaborating with renowned co-investors and experts to bring innovative cancer treatments to market. Radforsk's company portfolio showcases a range of successful investments in immunotherapy, highlighting their expertise and commitment to advancing cancer research. Their project portfolio is equally impressive, demonstrating their ability to identify and support promising research initiatives.
Additionally, Radforsk offers a podcast, Podkasten RADIUM, providing insightful discussions on the latest advancements in cancer treatment. Stay connected with Radforsk through their social media platforms, including Facebook, Twitter, and YouTube, to stay updated on their latest news and developments. With their unmatched dedication to oncology and their ability to commercialize cancer research, Radforsk is truly a force to be reckoned with in the field of cancer investment and innovation
Company type
Nonprofit
Year founded
1987
Company size
2-10 employees
